Thermo Fisher Scientific Stock Hits Day Low Amid Price Pressure at $472.08

Thermo Fisher Scientific, Inc., a prominent player in the Pharmaceuticals & Biotechnology sector, experienced a notable decline of 3.17% on March 27, 2026. The stock reached an intraday low of USD 472.08, reflecting broader market trends where the S&P 500 fell by 1.67% on the same day. Over the past week, Thermo Fisher's performance has been slightly negative, with a decrease of 0.22%, while the S&P 500 saw a larger drop of 2.12%. In the longer term, the stock has faced challenges, with a monthly decline of 9.16% compared to the S&P's 7.41%. Year-to-date, Thermo Fisher has dropped 18.31%, contrasting with the S&P 500's decline of 6.96%. Despite these recent setbacks, the company maintains a strong ability to service its debt, evidenced by a healthy EBIT to Interest ratio of 11.00. With a market capitalization of USD 195,607 million, Thermo Fisher continues to demonstrate solid long-term growth potential, as indicated by an annual net sales growth rate of 10.48%.